Inflammation in fat tissue helps prevent metabolic disease

Chronic tissue inflammation is typically associated with obesity and metabolic disease, but new research from UT Southwestern Medical Center now finds that a level of "healthy" inflammation is necessary to prevent metabolic diseases, such as fatty liver.

"There is such a thing as 'healthy' inflammation, meaning inflammation that allows the tissue to grow and has overall benefits to the tissue itself and the whole body," said Dr. Philipp Scherer, Director of the Touchstone Center for Diabetes Research and Professor of Internal Medicine and Cell Biology at UT Southwestern. "The same principle also applies in muscle: Exercise induces some inflammation in the tissue, but also leads to better and stronger muscles and, consequently, a healthier organism."

Using animal models, Dr. Scherer and his team, with first author, Dr. Ingrid Wernstedt Asterholm, former Assistant Instructor at UT Southwestern and current Assistant Professor at the University of Gothenburg in Sweden, found that suppressing inflammation in results in reduced fat expansion and thus leaner mice, even when the animals are fed a high-fat diet. The findings were first published online June 12 in Cell Metabolism.

What Dr. Scherer, holder of the Gifford O. Touchstone, Jr. and Randolph G. Touchstone Distinguished Chair in Diabetes Research, and his team expected to find that the reduced body fat content would lead to improvements in metabolism and a lower incidence of metabolic disease. Unexpectedly, the team found that the lean mice showed symptoms of metabolic disease, such as glucose intolerance.

This result might be because when fat tissue expands, it absorbs excess lipids, preventing them from being deposited in other tissues, such as the liver. Indeed, the animal models showed signs of fatty liver, caused by buildup of fat in liver cells, and a "leaky gut," caused by disruption of the gut wall.

"What our research shows is that we need some localized inflammation to remodel our fat tissue and to prevent such as fatty liver," said Dr. Asterholm. "This finding may explain in part why anti-inflammatory medicines have so far not been successful as anti-diabetic treatments. The effects of interventions that promote local low-level in fat tissue remain to be determined."

add to favorites email to friend print save as pdf

Related Stories

Natural hormone molds leaner bodies in mice

Jun 06, 2014

A natural hormone that is increased by physical exercise and by exposure to cold improves blood sugar control, suppresses inflammation, and burns fat to mold leaner bodies in mice, report scientists at Dana-Farber ...

Reducing liver protein SIRT1 levels

Jan 22, 2014

A new study led by Boston University School of Medicine (BUSM) demonstrates that the abnormal metabolism linked to obesity could be regulated in part by the interaction of two metabolic regulators, called the NAD-dependent ...

Recommended for you

New compounds reduce debilitating inflammation

Oct 24, 2014

Six Case Western Reserve scientists are part of an international team that has discovered two compounds that show promise in decreasing inflammation associated with diseases such as ulcerative colitis, arthritis and multiple ...

Asthma risk varies with ethnic ancestry among Latinos

Oct 07, 2014

Native American ancestry is associated with a lower asthma risk, but African ancestry is associated with a higher risk, according to the largest-ever study of how genetic variation influences asthma risk in Latinos, in whom ...

Asthma vaccine discovery

Oct 06, 2014

With asthma now affecting up to one in four New Zealand children, the researchers say this is a promising step in the challenge to understand and control asthma.

Phthalates heighten risk for childhood asthma

Sep 17, 2014

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used ...

User comments